Article

Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China

2021-09-05

Abstract excerpt

The SARS-CoV-2 B.1.617.2 (Delta) variant has caused a new surge in the number of COVID-19 cases. The effectiveness of vaccines against this variant is not fully understood. Using data from a recent large-scale outbreak of COVID-19 in China, we conducted a real-world study to explore the effect of inactivated vaccine immunization on the course of disease in patients infected with Delta variants. We recruited 476 co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ba32823b-7614-57f3-8d48-ee5ccd4daad0
DOI: 10.1101/2021.09.02.21263010

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, ChinaDOI 10.1101/2021.09.02.21263010Read

Effectiveness of Covid-19 Vaccines against the SARS-COV-2-Delta (B.1.617.2) in China-A Real World StudySemantic proximity Read

Effectiveness of Inactivated COVID-19 Vaccines Against COVID-19 Pneumonia and Severe Illness Caused by the B.1.617.2 (Delta) Variant: Evidence from an Outbreak in Guangdong, ChinaSemantic proximity Read

Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.Semantic proximity Read

Effectiveness of COVID-19 vaccines against delta variant (B.1.617.2): A meta-analysisSemantic proximity Read

Transmission dynamics and epidemiological characteristics of Delta variant infections in ChinaSemantic proximity Read

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.Semantic proximity Read

BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in QatarSemantic proximity Read

Herd immunity induced by COVID-19 vaccination programs and suppression of epidemics caused by the SARS-CoV-2 Delta variant in ChinaSemantic proximity Read

Current Review of Delta Variant of SARS-CoV-2Semantic proximity Read

Clinical outcomes in vaccinated individuals hospitalized with Delta variant of SARS-CoV-2Semantic proximity Read

Projected resurgence of COVID-19 in the United States in July—December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccinationSemantic proximity Read

SARS-CoV-2 Delta Variant Predominant at a Tertiary-Care Hospital in Saudi ArabiaSemantic proximity Read